
Director CNS Rad Onc | Assoc Prof Rad Onc @Georgetown @MedStarGUH | CNS Ca | Head & Neck Ca | Skin Ca | | @LombardiCancer | 🎹 |🐧 🏒
Washington, D.C.
Joined September 2016
- Tweets204
- Following210
- Followers157
- Likes148
Congrats to @KrcRebecca for publishing the @MarylandProton data supporting proton re-RT for recurrent H&N cancer with genomic data to drive personalized care.
authors.elsevier.com/c/1jBcv…
@RaneeMehra @UMarylandRadOnc #hncs @UMGCCC
Matthew Witek, MD, MS retweeted
#hncs congratulations to Dr @MatthewWitekMD and colleagues at university of Maryland for accomplishing a trial of rational contralateral volume reduction in oropharyngeal cancer. Cutting dose to organs at risk without contralateral failures in a relatively high risk cohort
Matthew Witek, MD, MS retweeted
Great presentation by Jason Molitoris discussing results of our Saver trial Contralateral de-escalation of p16+ OPC #HNCS24 @UMGCCC @MatthewWitekMD @HattenMD @UMarylandRadOnc
Matthew Witek, MD, MS retweeted
Big news for low risk HPV+ oropharyngeal cancer de-escalation. 60+cis did not meet non-inferiority threshold.
NRG-HN005 results of scheduled interim futility analysis comparing experimental arm to control arm for randomized phase II portion of the study showed that the experimental arm didn't achieve non-inferiority threshold per statistical analysis plan. conta.cc/3DRvsu2
Matthew Witek, MD, MS retweeted
We welcome the newest physician to our team!
Dr. Gregory Alexander from the Univ of Maryland.
@KimmelCancerCtr @JeffersonUniv @TJUHospital @JeffRadOnc
Matthew Witek, MD, MS retweeted
MSKCC @imrtlee reports that protons (IMPT) are less toxic than IMRT for patients with OPC cancer - confirms findings from Mayo @MayoClinic and MDACC @MDAndersonNews
https://xitter.gq/t.co/MM3GaMvdOm
Dr. Rodrigues and Dr. Molitoris at @MPTC are working on a new project “Image-guided #hyperthermia for the treatment of tumors.” Looking forward to reviewing the results.
4
Hodgkins Lymphoma survivors may have a higher risk of developing secondary lung cancer. #LungCancer
cancertherapyadvisor.com/hom…
Matthew Witek, MD, MS retweeted
Resident Dr. Bansi Savla @savlabansi will present The Impact of BMI and Residence in Food Priority Areas on Patterns-of-Care & Cancer Outcomes in Patients with Stage III #NSCLC 10/23, 4:45 PM, ex hall 1 at #ASTRO22. #healthdisparities #healthequity @PranshuMohindra @dr_dominica
Matthew Witek, MD, MS retweeted
Congratulations to Dr. William Regine and Dr. Mark Mishra @MarkMishraMD on being recognized as 2022 "Top Docs" by @Baltimoremag as they support our missions of patient care, research, education & outreach through passionate patient-centered care. ow.ly/HSZu50Levp4
Congratulations to our providers across the System for being recognized as Top Doctors by @Baltimoremag. These providers were recognized as the best in the region. Your care and dedication help ensure a better state of care for our patients. Learn more: ow.ly/HSZu50Levp4
Researchers discovered a new way to diagnose prostate cancer sooner. Earlier diagnosis means better outcomes for patients. #ProstateCancer#CancerDiagnosis
sciencedaily.com/releases/20…
1
Interesting read on HPV-related throat cancer and how the outcome in men varies by race and ethnicity. #ThroatCancer
physiciansweekly.com/hpv-rel…
Matthew Witek, MD, MS retweeted
I’m sorry but the ocean wants to kiss the moon sooooo bad like she’s obsessed
This Post is from a suspended account. Learn more
Matthew Witek, MD, MS retweeted
New UMB Center for Violence Prevention announced live next week. CMRO Rad Onc employee Liza Holley lost her 33-year-old son Daurell L. Hudson to gun violence & will speak at news conference on intervention & prevention. Livestream @UMBaltimore Sept. 6 at 12 pm ET. @shocktrauma
Matthew Witek, MD, MS retweeted
UM Vice Chairs for Research Dr. Phuoc Tran (left) and Med Physics Dr. @realAmitSawant (right), and Dr. @NickieSimone4 (Thomas Jefferson) will receive a 5 yr grant for >$7.5 million to co-lead the ROBIN OligoMET Center for primary and metastatic disease response to radiation
Check out the finding from a recent #clinicaltrial I worked on that focused on oropharynx cancer:
pubmed.ncbi.nlm.nih.gov/3544…
Matthew Witek, MD, MS retweeted
KEYNOTE-412 RCT (N=780) of pembrolizumab vs. placebo combined with conc. chemoRT followed by pembro as maintenance Tx failed to show a statistically significant improvement in event-free survival for unresected locally advanced HNSCC. No details available. merck.com/news/merck-provide…
Matthew Witek, MD, MS retweeted
Thank you for the kind words and passionate to continue advocating for our patients access to all radiation modalities in order to improve cure rates and reduce toxicity. #protons #brachytherapy #MARS #MRL @naptprotons @ASTRO_org @AmericanBrachy
Congratulations to the class of 2022 ASTRO Fellows who are members of the particle therapy community. @SJFrankMD of @MDAndersonNews serves on the Board of NAPT & the Physician Advisory Committee. We thank him for his leadership.























